Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa

Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa

Item
http://www.wikidata.org/entity/Q34680681
Canadian practice guidelines for surgical intra-abdominal infectionsCurrent concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosaA Pseudomonas aeruginosa EF-hand protein, EfhP (PA4107), modulates stress responses and virulence at high calcium concentrationTreatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposureEpidemiological interpretation of studies examining the effect of antibiotic usage on resistanceRelationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosaIncidence of Pseudomonas aeruginosa bacteremia: a population-based studyAntimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosaCorrelation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.
P2860

Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa

Item
http://www.wikidata.org/entity/Q34680681
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@ast
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@en
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@nl
type
label
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@ast
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@en
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@nl
prefLabel
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@ast
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@en
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Differential effects of levofl ...... sistant Pseudomonas aeruginosa
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932